Privacy Policy

OTC Publications is committed to ensuring that your privacy is protected. This privacy policy explains how we use the information we collect about you, how you can instruct us if you prefer to limit the use of that information and procedures that we have in place to safeguard your privacy.

1. The information we collect and how we use it

When you register for our website or post an opportunity, we need to know your name, company affiliation and e-mail address. We may also need to know your address, telephone number, credit card details and ask about the types of business opportunity in which you are interested.

We gather this information to allow us to process your registration and your request for our services. The relevant information is then used by us, our agents and sub-contractors to provide you with statements of your account and to communicate with you on any matter relating to the conduct of your account and the provision of our services in general.

We may also use aggregate information and statistics for the purposes of monitoring website usage in order to help us develop the website and our services and may provide such aggregate information to third parties. These statistics will not include information that can be used to identify any individual.

From time to time we may provide your information to our customer agencies for research and analysis purposes so that we can monitor and improve the services we provide. We or our agents and sub-contractors may contact you by e-mail or telephone to ask you for your feedback and comments on our services.

We and our group companies may also wish to provide you with information about other services or products of ours we think may be of interest to you. If you would rather not receive this information, please send an email to source@sourcegenerics.com.

We may also want to provide you with related information from third parties we think may be of interest to you. If you would rather not receive this information, please send an email to source@sourcegenerics.com.

We may also provide your information to carefully selected third parties, such as Generics bulletin, whose products or services we believe may be of interest to you. If you do not wish us to disclose your information in this way, please send an email to source@sourcegenerics.com.

2. Our use of cookies and other information gathering technologies

Cookies enable our system to recognise you when you visit our website again and improve our service to you. Cookies may also be used to compile aggregate information about areas of our website that are visited most frequently. This information can be used to enhance the content of our website and make your use of it easier. We do not track which pages you looked at while visiting our website. If you wish to reject our cookie, you can configure your browser to do so.

3. How we protect your information

The internet is not a secure medium. However, we have put in place various security procedures in order to prevent unauthorised access, to maintain data accuracy and to ensure the correct use of information, including the use of secure passwords, firewall technology, restricted access to certain parts of the website and browser certification technology.

4. Sale of business

If this business is sold or integrated with another business your details may be disclosed to our advisers and any prospective purchasers and their advisers and will be passed on to the new owners of the business.

5. Updating your details

If any of the information that you have provided to use changes, for example if you change your email address, name or payment details or if you wish to cancel your registration, please let us know the correct details by sending an email to source@sourcegenerics.com.

6. Your consent

By submitting your information you consent to the use of that information as set out in this policy. If we change our privacy policy we will post the changes on this page, and may place notices on other pages of the website, so that you may be aware of the information we collect and how we use it at all times. We will also email you should we make any changes so that you may consent to our use of your information in that way. Continued use of the service will signify that you agree to any such changes.

Owing to the global nature of the Internet infrastructure, the information you provide may be transferred in transit to countries outside the European Economic Area that do not have similar protections in place regarding you data and its use as set out in this policy, However, we have taken the steps outlined above to try to improve the security of your information. By submitting your information you consent to these transfers.

7. How to contact us

We welcome your views about our website and our privacy policy. If you would like to contact us with any queries or comments please send an email to source@sourcegenerics.com.

Testimonials

Einar Geir Hreinsson, Vice-President Strategic Projects at Actavis, says:
"We used this channel to reach potential customers and it turned out to be considerably more effective than we had expected. It is invaluable to be able to introduce a new project like Opening Pharma in this way, through a single portal with connections in all directions. This will be our first choice the next time we want to give a new project a good promotion."

Rich DiCicco, Chief Executive Officer of Harvest Moon Pharma, comments:
"Harvest Moon Pharma has listed its complex generics and biosimilars on SourceGenerics for three years. We have received enquiries from 206 companies - including Pfizer, Sanofi, Teva, Stada, Ranbaxy and Sandoz - from 58 countries, and we are very pleased with the results. We intend to keep listing on SourceGenerics indefinitely."

Sanjiv Puri, Chief Executive Officer of Australia's Generic Partners, tells us:
"Within a week of posting our business opportunities on SourceGenerics we had received over 10 quality enquiries from leading generics companies throughout the world."